VOYA INVESTMENT MANAGEMENT LLC
Position in CLDX — Celldex Therapeutics, Inc.
CIK 1068837
ATLANTA, GA
Position in CLDX
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$556,549
+$184,823 QoQ
Shares Held
14,957
+27.6% QoQ
Ownership
0.019%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#145
of 252 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in CLDX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026VOYA INVESTMENT MANAGEMENT LLC holds $1,414,582,516 across 196 Biotechnology names. CLDX ranks #102 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
505,219 | $250,957,432 | |
| 2 | PTGX |
Protagonist Therapeutics, Inc
|
571,618 | $70,068,932 | |
| 3 | SRRK |
Scholar Rock Holding Corp
|
890,607 | $48,983,385 | |
| 4 | KRYS |
Krystal Biotech, Inc.
|
124,442 | $46,251,357 | |
| 5 | TGTX |
Tg Therapeutics, Inc.
|
819,253 | $45,009,759 | |
| 6 | PTCT |
Ptc Therapeutics, Inc.
|
539,319 | $43,992,249 | |
| 7 | PRAX |
Praxis Precision Medicines, Inc.
|
122,227 | $40,920,376 | |
| 8 | REGN |
Regeneron Pharmaceuticals, Inc.
|
65,505 | $40,844,986 |
All Filings in CLDX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $556,549 | 14,957 | Shares | Defined | 2026-08-12 | |
| 2026-03-31 | $371,726 | 11,719 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $325,566 | 11,987 | Shares | Defined | 2026-02-12 | |
| 2025-09-30 | $310,103 | 11,987 | Shares | Defined | 2025-10-09 | |
| 2025-06-30 | $362,250 | 17,801 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $319,494 | 17,603 | Shares | Defined | 2025-06-18 | |
| 2024-12-31 | $491,956 | 19,468 | Shares | Defined | 2025-05-02 | |
| 2024-09-30 | $714,061 | 21,008 | Shares | Defined | 2025-02-07 | |
| 2024-06-30 | $796,270 | 21,515 | Shares | Defined | 2025-02-07 | |
| 2024-03-31 | $823,871 | 19,630 | Shares | Defined | 2025-02-07 | |
| 2023-12-31 | $736,922 | 18,581 | Shares | Defined | 2025-02-07 | |
| 2023-09-30 | $512,064 | 18,607 | Shares | Defined | 2025-02-07 | |
| 2023-06-30 | $624,074 | 18,393 | Shares | Defined | 2025-02-07 | |
| 2023-03-31 | $628,966 | 17,481 | Shares | Defined | 2025-02-07 | |
| 2022-12-31 | $785,769 | 17,630 | Shares | Defined | 2025-02-07 | |
| 2022-09-30 | $495,579 | 17,630 | Shares | Defined | 2025-02-07 | |
| 2022-06-30 | $475,304 | 17,630 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $612,262 | 17,976 | Shares | Defined | 2022-05-16 | |
| 2021-12-31 | $694,592 | 17,976 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $962,695 | 17,831 | Shares | Defined | 2021-11-15 | |
| 2021-06-30 | $516,347 | 15,441 | Shares | Defined | 2021-08-16 | |
| No filing history on record for this holder in this stock. | ||||||